Printer Friendly

Pediatric allergy study. (Product Marketplace).

Children with allergies who receive allergy shots are about half as likely to develop asthma as children not treated with shots, according to a study published in the February 2002 Journal of Allergy and Clinical Immunology.

The Preventive Allergy Treatment (PAT) study, conducted at six pediatric centers in Europe, followed the progress of disease in 205 children ages 6 to 14 with proven allergies to birch, grass pollen, or both. The children were randomly assigned to receive either medications alone to control the allergy symptoms or those medications and shots that treated their allergic condition. After 3 years of treatment, 24% of the children who received allergy shots developed mild asthma symptoms, compared with 44% of those who did not receive the treatment. Those receiving allergy shots also experienced less airway inflammation and fewer allergy symptoms.

Circle 161 on Reader Service Card
COPYRIGHT 2002 Medquest Communications, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Advertising; The Preventive Allergy Treatment study
Publication:Ear, Nose and Throat Journal
Article Type:Brief Article
Date:Apr 1, 2002
Words:142
Previous Article:Throat lubricant/moisturizer. (Product Marketplace).
Next Article:Euromed Clinic success. (Editorial).


Related Articles
New Drugs Engineered to Fight Asthma.
LIFE-THREATENING PEANUT ALLERGIES MAY BE PREVENTABLE.
Enzyme-potentiated desensitization in otolaryngic allergy.
Le Jacq Communications launches "SkinMed".
Food allergy: an overview. (Mini-Monograph).
Antibody treatment stifles peanut reactions. (Tough Nut Is Cracked).
Introduction.
Treatment and prevention of food allergies in breastfed infants: practice and evidence.
Pediatric allergic rhinitis: factors affecting treatment choice.
Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters